via latimes.com
A lawsuit by 15 states alleges that sales representatives of Thousand Oaks-based Amgen encouraged doctors and other healthcare providers to bill insurers for supplies of anemia drug Aranesp that the providers received free from the company. The practice allegedly cost taxpayer-funded Medicaid programs and other insurers millions of dollars in overpayments.
The lawsuit against Amgen focuses on a practice known as "overfill." Aranesp is often sold in one-dose vials. Pharmaceutical industry standards require that drug makers include a small amount of medicine in excess of the prescribed dosage -- known as overfill -- in such vials, according to the suit.
No comments:
Post a Comment